Skip to content

Cerus CERS Investment Purchases

Investment Purchases at other companies

CorMedix logo
CorMedixCRMD
$0-100%
Haemonetics logo
HaemoneticsHAE
$0-100%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$226.1M+47.4%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$68.97M-67.8%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's investment purchases?
Cerus (CERS) reported investment purchases of $8.41M in Q1 2026.
How has Cerus's investment purchases changed year-over-year?
Cerus's investment purchases increased by 5.6% year-over-year, from $7.96M to $8.41M.
What is the long-term trend for Cerus's investment purchases?
Over 4 years (2021 to 2025), Cerus's investment purchases has grown at a -4.8% compound annual growth rate (CAGR), from $52.07M to $42.78M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.